<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Telehealth</title>
	<atom:link href="https://www.worldpharmatoday.com/topics/telehealth/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Wed, 20 May 2026 10:35:31 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Telehealth</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Decentralized Clinical Trials Market Advances Worldwide</title>
		<link>https://www.worldpharmatoday.com/clinical-trails/decentralized-clinical-trials-market-advances-worldwide/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Wed, 20 May 2026 10:35:31 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Telehealth]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/decentralized-clinical-trials-market-advances-worldwide/</guid>

					<description><![CDATA[<p>The global Decentralized Clinical Trials Market is expected to grow from USD 9.74 billion in 2025 to USD 34.13 billion by 2035, registering a compound annual growth rate (CAGR) of 13.36% during the forecast period from 2026 to 2035. The market is expanding as pharmaceutical companies, biotechnology firms, contract research organizations, and healthcare technology providers [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/clinical-trails/decentralized-clinical-trials-market-advances-worldwide/">Decentralized Clinical Trials Market Advances Worldwide</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Future Trends in Pharmaceutical Drug Delivery Platforms</title>
		<link>https://www.worldpharmatoday.com/drug-research/future-trends-in-pharmaceutical-drug-delivery-platforms/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 06 Feb 2026 11:46:15 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[IT & Data Management]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<category><![CDATA[Biopharmaceutical Development]]></category>
		<category><![CDATA[Customised Solutions]]></category>
		<category><![CDATA[Telehealth]]></category>
		<category><![CDATA[Treatments]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/future-trends-in-pharmaceutical-drug-delivery-platforms/</guid>

					<description><![CDATA[<p>Forward-looking perspective on the convergence of digital technology, bioengineering, and material science in creating the next generation of therapeutic delivery systems.</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/future-trends-in-pharmaceutical-drug-delivery-platforms/">Future Trends in Pharmaceutical Drug Delivery Platforms</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for MeteredDose Inhalers</title>
		<link>https://www.worldpharmatoday.com/press-releases/aptar-digital-health-announces-fda-510k-clearance-for-herotracker-sense-a-connected-add-on-device-for-metereddose-inhalers/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 18 Oct 2025 08:32:39 +0000</pubDate>
				<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Telehealth]]></category>
		<category><![CDATA[Treatments]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/aptar-digital-health-announces-fda-510k-clearance-for-herotracker-sense-a-connected-add-on-device-for-metereddose-inhalers/</guid>

					<description><![CDATA[<p>Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HeroTracker® Sense as a Class II medical device. This milestone recognizes HeroTracker® Sense &#8211; a Bluetooth-enabled sensor &#8211; as an innovative connected add-on for pressurized Metered [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/press-releases/aptar-digital-health-announces-fda-510k-clearance-for-herotracker-sense-a-connected-add-on-device-for-metereddose-inhalers/">Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for MeteredDose Inhalers</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
